It sounds like there may be two questions here — one about Empaveli, and one about stage 3 kidney disease diagnostics. Here's a breakdown of both!
About Empaveli
Empaveli (pegcetacoplan) is an FDA-approved medication, but it's specifically approved for two rare kidney conditions:
- C3 Glomerulopathy (C3G)
- Primary Show Full Answer
It sounds like there may be two questions here — one about Empaveli, and one about stage 3 kidney disease diagnostics. Here's a breakdown of both!
About Empaveli
Empaveli (pegcetacoplan) is an FDA-approved medication, but it's specifically approved for two rare kidney conditions:
- C3 Glomerulopathy (C3G)
- Primary Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
It works by targeting proteins in the immune system that cause kidney damage in these conditions. It's given as an injection under the skin twice a week. About Stage 3 Kidney Disease Diagnostics
Stage 3 CKD is identified using a blood test that measures your eGFR (estimated glomerular filtration rate) — basically how well your kidneys are filtering your blood:
- Stage 3a — eGFR between 45 and 59
- Stage 3b — eGFR between 30 and 44
A urine test may also be done to check for protein in the urine, which is a sign the kidneys aren't working as well as they should.
At this stage, your doctor may also order imaging or other tests to get a clearer picture of your kidney health.
It's worth noting that Empaveli is not typically used for general stage 3 CKD — it's specifically for C3G or IC-MPGN. Always check with your doctor to see what treatments are right for your specific situation.
September 25
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
